Competitor Analysis: Anti-Inflammatory Peptides
Competitor Analysis: Anti-Inflammatory Peptides
The present Competitive Intelligence Report about peptides therapeutics provides a competitor evaluation in the field of marketed and new molecules for treatment of inflammatory and autoimmune diseases as of September 2014. Anti-Inflammatory peptides under development and on the market are used for treatment of diseases ranging from psoriasis, multiple sclerosis, transplantation and autoimmune diseases.Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently marketed and active projects in research and development of anti-inflammatory peptides. In addition, the report lists company-specific R&D pipelines of anti-inflammatory peptides. Competitor projects are listed in a tabular format providing information on:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The present Competitive Intelligence Report about peptides therapeutics provides a competitor evaluation in the field of marketed and new molecules for treatment of inflammatory and autoimmune diseases as of September 2014. Anti-Inflammatory peptides under development and on the market are used for treatment of diseases ranging from psoriasis, multiple sclerosis, transplantation and autoimmune diseases.Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently marketed and active projects in research and development of anti-inflammatory peptides. In addition, the report lists company-specific R&D pipelines of anti-inflammatory peptides. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
2013 Sales of Major Anti-Inflammatory Peptides
Cardiovascular Diseases
Dermatological Diseases
Gastrointestinal Diseases
Neurological Diseases
Ophthalmological & Otorhino Diseases
Pulmonary & Respiratory Diseases
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation
Not-Specified Inflammatory & Autoimmune Diseases
Corporate Anti-Inflammatory Peptide R&D Pipelines
Cardiovascular Diseases
Dermatological Diseases
Gastrointestinal Diseases
Neurological Diseases
Ophthalmological & Otorhino Diseases
Pulmonary & Respiratory Diseases
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation
Not-Specified Inflammatory & Autoimmune Diseases
Corporate Anti-Inflammatory Peptide R&D Pipelines
